Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,898,935
-
Total 13F shares
-
51,170,611
-
Share change
-
-303,528
-
Total reported value
-
$3,788,844,813
-
Put/Call ratio
-
137%
-
Price per share
-
$74.03
-
Number of holders
-
254
-
Value change
-
-$10,995,011
-
Number of buys
-
129
-
Number of sells
-
114
Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q3 2022
As of 30 Sep 2022 HAEMONETICS CORP - Common Stock (HAE) had 254 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 51,170,611 shares of stock of the company.
Largest 10 holders included Capital Research Global Investors, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, Neuberger Berman Group LLC, STATE STREET CORP, FRANKLIN RESOURCES INC, Fisher Asset Management, LLC, SCHRODER INVESTMENT MANAGEMENT GROUP, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 255 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.